Venetoclax First Cycle Treatment in a Case of Severe AML FAB M2 and COVID-19 Pneumoniae: A Rare Clinical Scenario
Asian Hematology Research Journal · pp. 12–18 · Published 25 Jan 2021
Abstract
Here we describe a rare case of a venetoclax first cycle treatment in a case of a newly diagnosed COVID-19 pneumoniae.
Cited by 0
No indexed citations yet.
Related research
- Thrombocytopenia-absent Radius Syndrome with Vitamin B12 Deficiency: Case Report with Literature Review — shares topic coverage
- A Study on Relationship of Thrombocytopenia and Likelihood of Severe Malaria in Patients Admitted With Malaria in a Tertiary Care Hospital of Dakshina Kannada — shares topic coverage
- Platelet Alteration in Plasmodium vivax Malaria Patients in Thailand — shares topic coverage
- The Incidence of Hypersplenism in Decompensated Liver Cirrhosis of Alcoholic Etiology — shares topic coverage
- Audit of Platelets Usage among Patients: A Descriptive Study of Various Platelet Concentrates — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.